Julie Domingo of Cannareps: The highest quality strains out there for medicinal patients

Julie Domingo, CEO of Cannareps

Julie Domingo, CEO of Cannareps

Written by Leah Maurer   

With more research coming out about cannabis, medical patients are able to learn more about how different strains of cannabis affect their bodies and why. Everyone’s endocannabinoid system is different, so different strains/varieties likely affect all of our bodies in a different way. But, is there a way to know what the highest quality of strains are for medical cannabis patients?


Julie Domingo is the CEO of Cannareps, a cannabis education platform that features in-person classes led by pioneering industry experts with hands-on learning with tried-and-true formulas. The company began because they saw the negative impacts of the misinformation and lack of support for medical cannabis patients. Julie came to the company after 13 years of award-winning accomplishments, including being the GM that led Aura Cannabis to win Lift & Co. awards 3 years in a row. She was also the first compassion club business license in Vancouver.


When asked how a medicinal cannabis patient figure out what strains work best for their particular wellness needs, Julie explained, “The medical/recreational labeling of cannabis is a false dichotomy; really it’s about the person and you don’t have to label why you are using cannabis. People are searching for efficacy, and at this time there must be some degree of trial and error before you find that perfect effect. When it comes down to it, the correct cannabinoid ratio and correct modality are what consumers need to look at most closely.”


Julie went on to explain that their team has seen over many years how an individual will respond to a complex cannabis variation. “A variety does not always grow the same cannabinoid or terpene ratio, which is what cannabis consumers should be looking at when they are trying out different strains for different desired affects.” She suggests to start with CBD (only) and increase the (CBD) dose until you feel it. If you still don’t feel it, try adding in THC gradually. Until we have more validated research, there is no cut and dry answer, but certain strains are more affective than others. Julie said, “ It is more important to look at cannabinoid ratios and terpene profiles, or correct CBD/THC ratio if it’s a product without terpenes.”


She went on to explain that patients should find the niche and gene pool that works best for their bodies, which means looking at it as much more than indica, sativa, or hybrid. It’s really all about the ratios and lineage of the cannabis and the profile of the plant. Typically, product name and potency is all consumers can see when they go to cannabis retail shops/dispensaries but, as Julie highlighted, there are so many other parameters that play into this, and it’s really about what quality means to you and your body. Cannareps helps determine that through their education, Grow Tech Labs works with Cannareps and Julie said, “I consider our relationship to be friends first and then business. We help each other network and open doors for each other, and facilitate and add credibility to each other. I am so excited about the Grow Tech Labs Accelerator Program because their foundational education is so important, and Cannareps helps with that because we can cater to the needs for each sector of the cannabis industry and can help provide the training.